Zachary Brennan has joined Politico to cover FDA regulations as part of the company’s expanded coverage of pharma policy. Brennan will be enhancing Politico’s pharma coverage during the ongoing pandemic and will also be acting as an expert contributor to Politico’s Agency IQ platform.
His new role begins this week.
Currently, he holds the post of managing editor at the Regulatory Affairs Professionals Society. He is also the author of FDA-focused publication, Regulatory Focus.
Before joining RAPS, Brennan was a pharmaceutical editor at William Reed Business Media Focus. He also served as an international editor at FDAnews and as a speechwriter at the U.S. Department of Transportation.
In addition, he was an editor with The Bulletin News Network and held the post of staff writer at The Advisory Board Company.
Brennan is a B.A. in English from Northwestern University.
The Wall Street Journal is looking for an editor to lead its coverage of logistics…
The Wall Street Journal seeks an enterprising and ambitious reporter to cover the intersection of…
The Wall Street Journal is seeking a reporter in Washington, DC, to chronicle one of…
Reuters has hired Wall Street Journal reporter Anna Hirtenstein. She will start next month. Hirtenstein has…
Caroline Gage, head of the Americas for Bloomberg News, sent the following announcement to staff:…
Forbes senior editor Amy Feldman is now covering health care. She had been covering industrial innovation and…